Atjaunināt sīkdatņu piekrišanu

E-grāmata: Advanced Handbook of Methods in Evidence Based Healthcare

Edited by , Edited by , Edited by , Edited by , Edited by
  • Formāts: 544 pages
  • Izdošanas datums: 02-Jan-2001
  • Izdevniecība: SAGE Publications Inc
  • Valoda: eng
  • ISBN-13: 9781847876751
Citas grāmatas par šo tēmu:
  • Formāts - PDF+DRM
  • Cena: 107,07 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: 544 pages
  • Izdošanas datums: 02-Jan-2001
  • Izdevniecība: SAGE Publications Inc
  • Valoda: eng
  • ISBN-13: 9781847876751
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

This handbook is an excellent reflection of the growing maturity and methodological sophistication of the field of Health Technology Assessment. The Handbook covers a spectrum of issues, from primary evidence (clinical trials) through reviews and meta-analysis, to identifying and filling gaps in the evidence. Up-to-date, clearly written, and well-edited, the handbook is a needed addition to any personal or professional library dealing with Health Technology Assessment. Professor David Banta, TNO Prevention and Health, The Netherlands









This text presents the most advanced knowledge on methodology in health care research, and will form the backbone of many future studies - Paula Roberts, Nurse Researcher









The `effectiveness revolution both in research and clinical practice, has tested available methods for health services research to the extreme. How far can observational methods, routine data and qualitative methods be used in health care evaluation? What cost and outcome measures are appropriate, and how should data be gathered?









With the support of over two million pounds from the British Health Technology Assessment Research Programme, the research project for this Handbook has led to both a synthesis of all of the existing knowledge in these areas and an agenda for future debate and research.









The chapters and their authors have been selected through a careful process of peer review and provide a coherent and complete approach to the field. The handbook has been a unique collaboration between internationally regarded clinicians, statisticians, epidemiologists, social scientists, health economists and ethicists. It provides the most advanced thinking and the most authoritative resource for a state of the art review of methods of evaluating health care and will be required reading for anyone involved in health services research and management.

Recenzijas

`As books go, this is a real heavyweight. It is physically big, with 27 chapters running to over 500 pages. It is expensive, coming in at £69. Yet it is heavyweight in another sense. Some of the chapter authors are heavyweights, leaders, in their fields and this shines through veryc learly in the text. This book aims to provide readers with an insight into some of the most advanced methods involved in evidence based healthcare. Whey we see the word "advanced" we sometimes worry about things being set out in complex, convoluted, over-your-head, impenetrable, coded and cluttered language. Happily, most of this book is clear, comprehensive and concise. A few of the chapters are more challenging to read but they are certainly worth the extra effort.



The book has six sections covering 27 chapters Inside each section lies between three-to-five chapters. Each chapter is clearly laid out and referenced.



While it is a methods book, the chapter authors sprinkle a good dose of real examples through the text to reinforce some of their points. This certainly helps to keep the writing fresh and engaging.



The book is essentially derived from a large collection of UK NHS Health Technology Assessment (HTA) reports, which are available free of charge from the HTA program. If you want a lot of material in one cover, and if you want to make real progress in understanding some of the latest developments and thinking in evidence based healthcare, this is the only book to buy -British Journal of Clinical Governance









Among the many features of the UK National Health Services Research & Development (NHS R&D) Programme that deserve admiration is its commitment to systematically evaluating which methods to use to obtain the best possible evidence for healthcare decisions. Reviews of a wide range of methodological issues relevant to health technology assessment have been commissioned by the NHS R&D Programme. Andrew Stevens and Ray Fitzpatrick have done an admirable job organising and editing this wealth of information. The Advanced Handbook of Methods in Evidence Based Health Care provides a unique and valuable reference for anyone wanting to make well informed decisions about methods of evaluating healthcare.



Dr Andy Oxman, Director Health Services Research Unit National



Institute of Public Health Postboks 4404 Torshov 0403 Oslo NORWAY









This book promises to become a standard work of reference for all those interested in the methods of HTA and their application. Each topic is introduced seductively through successive levels of detail, so that there is material here for a variety of readers having a variety of interests, from those who want merely to capture some of the jargon to those at the leading edge of methodological development. As a would-be multi-disciplinarian, I found enlightenment almost everywhere.



Professor Tony Culyer, Professor of Economics and Head of the Department of Economics and Related Studies, University of York









This handbook is an excellent reflection of the growing maturity and methodological sophistication of the field of Health Technology Assessment. The handbook covers a spectrum of issues, from primary evidence (clinical trials) through reviews and meta-analysis, to identifying and filling gaps in the evidence. Up-to-date, clearly written, and well-edited, the handbook is a needed addition to any personal or professional library dealing with Health Technology Assessment.



Professor David Banta, TNO Prevention and Health, The Netherlands









It is very heartening to see so much of the methodological work that the HTA programme has commissioned brought together in one volume, a volume that is technical and authoritative but also readable and accessible. As NICE gets into full swing as the key national body with responsibility for promoting clinical excellence and cost-effective care within the NHS, it is particularly timely that these groundbreaking pieces of work should be published. Clearly much remains to be done. Nevertheless, this handbook will set new standards for those undertaking health technology assessments as well as map out the next generation of methodological challenges.



Dr Ruairidh Milne, Scientific Director, National Co-ordinating Centre for Health Technology Assessment









Health care research is expanding rapidly, aided by the fruitful interaction of a range of academic disciplines. Since its inception in 1993, the NHS Health Technology Assessment Programme has had two distinctive themes, a multi-disciplinary approach and a strategy to develop the methodological basis for HTA. This timely volume brings together a wide range of work commissioned by the Programme on methodology. Contributions from a diverse group of active health service researchers - statisticians, health economists, clinicians, sociologists and others - give a wide ranging overview of assessment strategies in health care. The scope includes quantitative and qualitative methods, randomised and non-randomised designs and the measurement of costs and benefits in health economic analysis. A number of active themes in statistical analysis, research synthesis and horizon scanning are considered. The volume will be of value to researchers wishing to keep abreast of methodological developments across the wide field of health care. For those who plan, provide or use health services it will provide a unique insight into the development of the knowledge base upon which modern health care rests.



Professor Kent Woods, Director NHS HTA Programme









The impact of clinical trials on health policy development is almost as great as the impact on clinical practice. Around the world many agencies are now struggling to make the best use of data from clinical trials, experimental studies and observational studies in order to make the best decisions about what technology to subsidise and at what price. This book covers a very wide field of technical issues regarding the appropriate use of data in health technology assessment. Undoubtedly it will become a major resource for everyone working in this field.



Professor David Henry, Professor of Clinical Pharmacology, Head of Discipline of Clinical Pharmacology, Faculty of Medicine and Health Sciences, the University of Newcastle, Australia









This text presents the most advanced knowledge on methodology in health care research, and will form the backbone of many future studies - Paula Roberts, Nurse Researcher

Contributors ix Introduction Methods in Evidence Based Healthcare and Health Technology Assessment: An Overview 1(6) Andrew Stevens Ray Fitzpatrick Keith Abrams John Brazier Richard Lilford Part I Clinical Trials Introduction 7(4) Richard Lilford Andrew Stevens Ethical Issues in the Design and Conduct of Randomised Controlled Trials 11(14) Richard J. Lilford Sarah J.L. Edwards David A. Braunholtz Jennifer Jackson Jim Thornton Jenny Hewison Ethics of Clinical Trials: Social, Cultural and Economic Factors 25(13) Richard E. Ashcroft Factors that Limit the Number, Progress and Quality of Randomised Controlled Trials: A Systematic Review 38(18) Sue Ross Carl E. Counsell William J. Gillespie Adrian M. Grant Robin J. Prescott Ian T. Russell Iain R. Colthart Sandra Kiauka Daphne Russell Sue M. Shepherd Results of Clinical Trials and Systematic Reviews: To Whom Do They Apply? 56(17) Dianne OConnell Paul Glasziou Suzanne Hill Jasminka Sarunac Julia Lowe David Henry The Placebo Effect: Methodological Process and Implications of a Structured Review 73(22) Rosemary Crow Heather Gage Sarah Hampson Jo Hart Alan Kimber Hilary Thomas Part II Observational and Qualitative Methods Introduction 91(4) Ray Fitzpatrick Randomised and Non-Randomised Studies: Threats to Internal and External Validity 95(21) Colin Sanderson Martin McKee Annie Britton Nick Black Klim McPherson Chris Bain A Review of Observational, Quasi-Experimental and Randomised Study Designs for the Evaluation of the Effectiveness of Healthcare Interventions 116(20) Barnaby C. Reeves Rachel R. MacLehose Ian M. Harvey Trevor A. Sheldon Ian T. Russell Andrew M.S. Black The Potential Use of Routine Datasets in Health Technology Assessment 136(13) James Raftery Andrew Stevens Paul Roderick Using Routine Data to Complement and Enhance the Results of Randomised Controlled Trials 149(17) James D. Lewsey Gordon D. Murray Alastair H. Leyland F. Andrew Boddy Qualitative Methods in Health Technology Assessment 166(15) Elizabeth Murphy Robert Dingwall Part III Measurement of Benefit And Cost Introduction 179(2) John Brazier Criteria for Assessing Patient Based Outcome Measures for Use in Clinical Trials 181(14) Ray Fitzpatrick Claire Davey Martin J. Buxton David R. Jones The Use of Health Status Measures in Economic Evaluation 195(20) John Brazier Mark Deverill Colin Green Collecting Resource Use Data for Costing in Clinical Trials 215(16) Katharine Johnston Martin J. Buxton David R. Jones Ray Fitzpatrick Eliciting Time Preferences for Health 231(16) John Cairns Marjon van der Pol The Conduct and Design of Questionnaire Surveys in Healthcare Research 247(28) Elaine McColl Ann Jacoby Lois Thomas Jennifer Soutter Claire Bamford Nick Steen Roger Thomas Emma Harvey Andrew Garratt John Bond Part IV Analytical Methods Introduction 273(2) Keith R. Abrams Bayesian Methods 275(20) David J. Spiegelhalter Jonathan P. Myles David R. Jones Keith R. Abrams Methods for Evaluating Organisation- or Area-Based Health Interventions 295(19) Martin Gulliford Obioha C. Ukoumunne Susan Chinn Jonathan Sterne Peter Burney Allan Donner Handling Uncertainty in Economic Evaluation 314(24) Andrew H. Briggs Alastair M. Gray A Review of the Use of the Main Quality of Life Measures, and Sample Size Determination for Quality of Life Measures, Particularly in Cancer Clinical Trials 338(14) Michael J. Campbell Steven A. Julious Sarah J. Walker Steve L. George David Maching Simultaneous Analysis of Quality of Life and Survival Data 352(19) Lucinda J. Billingham Keith R. Abrams David R. Jones Part V Consensus, Reviews And Meta-Analysis Introduction 367(4) Andrew Stevens Keith R. Abrams Publication and Related Biases 371(20) Fujian Song Alison Eastwood Simon Gilbody Lelia Duley Alex Sutton Meta-Analysis in Health Technology Assessment 391(18) Alexander J. Sutton David R. Jones Keith R. Abrams Trevor A. Sheldon Fujian Song Assessing the Quality of Reports of Randomised Trials Included in Meta-Analyses: Attitudes 409(17) Practice Evidence David Moher Terry P. Klassen Alison L. Jones Ba Pham Deborah J. Cook Alejandro R. Jadad Peter Tugwell Michael Moher Consensus Development Methods, and their Use in Creating Clinical Guidelines 426(25) Nick Black Maggie Murphy Donna Lamping Martin McKee Colin Sanderson Janet Askham Theresa Marteau Part VI Identifying And Filling Gaps In The Evidence Introduction 449(2) Andrew Stevens Identifying New Healthcare Technologies 451(20) Glenn Robert Andrew Stevens John Gabbay Timing of Assessment of Fast-Changing Health Technologies 471(14) Graham Mowatt Adrian M. Grant D. Jane Bower John A. Brebner John A. Cairns Lorna McKee Preliminary Economic Evaluation of Health Technologies 485(14) Gareth Harper Joy Townsend Martin Buxton Index 499
Andrew Stevens is Professor of Public Health and former Head of Department and Division (of Primary Care, Public and Occupational Health).

Andrew is interested in Health Services Research including health care needs assessment, health technology assessment and horizon scanning. He has edited the 4 volume Health Care Needs Assessment Series, and the Advanced Handbook of Methods in Evidence Based Healthcare.

Andrew has had a close involvement with the National Institute for Health and Clinical Excellence (NICE) since its establishment in 2000, and has been Chairman of one of its Appraisal Committees for 6 years. Porf. Adrams research includes: The development and application of Bayesian methods in healthcare evaluation, systematic reviews and meta-analysis and The joint modelling of longitudinal and time-to-event data. He has considerable experience of undertaking pradmatic TCTs and systematic reviews in a variety of settings, including cardiology, gastroenology, oncology and reproductive medicine. John Brazier is Professor of Health Economics at the Health Economics and Decision Science section of the School of Health and Related Research at the University of Sheffield. He has more than 20 years experience of conducting economic evaluations of health care interventions for policy makers. He has also undertaken numerous economic evaluations alongside clinical trials and decision analytic models. He has a particular interest in the measurement and valuation of health for economic evaluation where he has published widely. He is perhaps best known for his work in developing a preference-based measure of health for the SF-36, but more recently has extended these methods to a number of specific condition including measures in asthma, cancer, overactive bladder, dementia and epilepsy. More recently he has been developing ways to incorporate equity concerns such as burden of disease into the weights applied to QALYs for Value Based Pricing. He is Director of an Economic Evaluation Policy Research Unit (EEPRU) that is funded by the Department of Health in England. He was a member of the National Institute for Clinical Excellence (NICE) Technology Appraisal Committee from 2000-2004 and is a member of the Working Group on revising Methods of Economic Evaluation for Technology Appraisal in 2012.